{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:09:11Z","timestamp":1785164951237,"version":"3.55.0"},"reference-count":98,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/aosk8903","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:21:39Z","timestamp":1737519699000},"page":"47-59","source":"Crossref","is-referenced-by-count":9,"title":["Regulatory mechanisms of m6A methylation in dilated cardiomyopathy"],"prefix":"10.62347","volume":"17","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","unstructured":"Heymans S, Lakdawala NK, Tschöpe C and Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet 2023; 402: 998-1011.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","unstructured":"Haas J, Frese KS, Peil B, Strom TM, Pfeufer A, Kloos W, Ott CE, Gabunia K, Hinzmann C, Fuchs M, Rottbauer W, Wichmann HE, Meitinger T, Stucka R, Kääb S, Katus HA and Keller S. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015; 36: 1123-1135.","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2019.10.011","article-title":"Precision medicine in the management of dilated cardiomyopathy: JACC state-of-the-art review","volume":"74","author":"Fatkin","year":"2019","unstructured":"Fatkin D, Huttner IG, Kovacic JC, Seidman JG, Seidman CE and Ashley EA. Precision medicine in the management of dilated cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019; 74: 2921-2938.","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","unstructured":"Japp AG, Gulati A, Cook SA, Cowie MR and Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 2016; 67: 2996-3010.","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/jcdd9060174","article-title":"A comprehensive outlook on dilated cardiomyopathy (DCM): state-of-the-art developments with special emphasis on OMICS-based approaches","volume":"9","author":"Sarohi","year":"2022","unstructured":"Sarohi V, Srivastava S and Basak T. A comprehensive outlook on dilated cardiomyopathy (DCM): state-of-the-art developments with special emphasis on OMICS-based approaches. J Cardiovasc Dev Dis 2022; 9: 174.","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1161\/CIRCRESAHA.121.318157","article-title":"The complex and diverse genetic architecture of dilated cardiomyopathy","volume":"128","author":"Hershberger","year":"2021","unstructured":"Hershberger RE, Cowan J, Jordan E and Kinnamon DD. The complex and diverse genetic architecture of dilated cardiomyopathy. Circ Res 2021; 128: 1514-1532.","journal-title":"Circ Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T and Pan T. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011; 7: 885-887.","journal-title":"Nat Chem Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, Vågbø CB, Shi Y, Wang WL, Song SH, Lu Z, Bosmans RP, Dai Q, Hao YJ, Yang X, Zhao WM, Tong WM, Wang XJ, Bogdan F, Furu K, Fu Y, Jia G, Zhao X, Liu J, Krokan HE, Klungland A, Yang YG and He C. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 2013; 49: 18-29.","journal-title":"Mol Cell"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Ge L, Zhou Q, Mao Z and Hu B. Functions of N6-methyladenosine and its role in cancer. Mol Cancer 2019; 18: 1-15.","journal-title":"Mol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","unstructured":"Huang H, Weng H and Chen J. m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell 2020; 37: 270-288.","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cr.2017.10","article-title":"Cytoplasmic m6A reader YTHDF3 promotes mRNA translation","volume":"27","author":"Li","year":"2017","unstructured":"Li A, Chen YS, Ping XL, Yang X, Xiao W, Yang Y, Sun HY, Zhu Q, Cheng CY, Zhang X, He C and Wang XJ. Cytoplasmic m6A reader YTHDF3 promotes mRNA translation. Cell Res 2017; 27: 444-447.","journal-title":"Cell Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","article-title":"mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification","volume":"118","author":"Kumari","year":"2022","unstructured":"Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J and Kumar S. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res 2022; 118: 1680-1692.","journal-title":"Cardiovasc Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"113712","DOI":"10.1016\/j.yexcr.2023.113712","article-title":"m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3\/miRNA-193a\/BCL2L2 pathway","volume":"430","author":"Liang","year":"2023","unstructured":"Liang L, Liu S, Wu Q, Chen R, Jiang S and Yang Z. m6A-mediated upregulation of miRNA-193a aggravates cardiomyocyte apoptosis and inflammatory response in sepsis-induced cardiomyopathy via the METTL3\/miRNA-193a\/BCL2L2 pathway. Exp Cell Res 2023; 430: 113712.","journal-title":"Exp Cell Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10863-024-10006-1","article-title":"Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner","volume":"56","author":"Tang","year":"2024","unstructured":"Tang Z, Huang X, Mei H and Zheng Z. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner. J Bioenerg Biomembr 2024; 56: 149-157.","journal-title":"J Bioenerg Biomembr"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Zhuang Y, Li T, Hu X, Ma Y, Wang Y and Chen J. MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification. FASEB J 2023; 37: e22797.","DOI":"10.1096\/fj.202201734R"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"10879","DOI":"10.1111\/jcmm.16955","article-title":"Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin","volume":"25","author":"Gao","year":"2021","unstructured":"Gao S, Sun H, Chen K, Li L, Liu X, Wang Y and Zhang Y. Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin. J Cell Mol Med 2021; 25: 10879-10891.","journal-title":"J Cell Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"119186","DOI":"10.1016\/j.lfs.2021.119186","article-title":"Epigenetics-based therapeutics for myocardial fibrosis","volume":"271","author":"Li","year":"2021","unstructured":"Li X, Yang Y, Chen S, Zhou J, Li J and Cheng Y. Epigenetics-based therapeutics for myocardial fibrosis. Life Sci 2021; 271: 119186.","journal-title":"Life Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"122922","DOI":"10.1016\/j.lfs.2024.122922","article-title":"m6A control programmed cell death in cardiac fibrosis","volume":"353","author":"Liu","year":"2024","unstructured":"Liu ZY, You QY, Liu ZY, Lin LC, Yang JJ and Tao H. m6A control programmed cell death in cardiac fibrosis. Life Sci 2024; 353: 122922.","journal-title":"Life Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","article-title":"RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing","volume":"18","author":"Guo","year":"2012","unstructured":"Guo W, Schafer S, Greaser ML, Radke MH, Liss M, Neuber C, Schaelling B, Mertins P, Gotthardt M and Krüger M. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 2012; 18: 766-773.","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"van den Hoogenhof","year":"2018","unstructured":"van den Hoogenhof MMG, Beqqali A, Amin AS, Van Der Made I, Aufiero S, Marsman RF, Pinto YM and Creemers EE. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling. Circulation 2018; 138: 1330-1342.","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","unstructured":"McNally EM and Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res 2017; 121: 731-748.","journal-title":"Circ Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","unstructured":"Lee J, Termglinchan V, Diecke S, Lau E, Greenhaw M, Matsa E and Wu JC. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature 2019; 572: 335-340.","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.forsciint.2006.06.044","article-title":"Myocardial Cx43 expression in the cases of sudden death due to dilated cardiomyopathy","volume":"162","author":"Chen","year":"2006","unstructured":"Chen X and Zhang Y. Myocardial Cx43 expression in the cases of sudden death due to dilated cardiomyopathy. Forensic Sci Int 2006; 162: 170-173.","journal-title":"Forensic Sci Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvn083","article-title":"Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy","volume":"79","author":"Birks","year":"2008","unstructured":"Birks EJ, Latif N, Enesa K, Khan M, Bowles CT, Eastwood M, French B, Mughal M, MacGowan GA and Yacoub MH. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res 2008; 79: 472-480.","journal-title":"Cardiovasc Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ygeno.2016.07.001","article-title":"Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy","volume":"108","author":"BS","year":"2016","unstructured":"Jo BS, Koh IU, Bae JB, Choi SH, Kim YS, Nam HY and Kang C. Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy. Genomics 2016; 108: 84-92.","journal-title":"Genomics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1152\/physiolgenomics.00013.2013","article-title":"Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis","volume":"45","author":"Koczor","year":"2013","unstructured":"Koczor CA, Lee EK, Torres RA, Boyd AR, Vega JD and Zile MR. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics 2013; 45: 597-605.","journal-title":"Physiol Genomics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1002\/jcp.31085","article-title":"m6A regulator-mediated RNA methylation modification remodels immune microenvironment in dilated cardiomyopathy","volume":"238","author":"Luo","year":"2023","unstructured":"Luo Z, Cheng J and Wang Y. m6A regulator-mediated RNA methylation modification remodels immune microenvironment in dilated cardiomyopathy. J Cell Physiol 2023; 238: 2282-2292.","journal-title":"J Cell Physiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","article-title":"Regulated cell death pathways in cardiomyopathy","volume":"44","author":"Sheng","year":"2023","unstructured":"Sheng SY, Li JM, Hu XY and Wang Y. Regulated cell death pathways in cardiomyopathy. Acta Pharmacol Sin 2023; 44: 1521-1535.","journal-title":"Acta Pharmacol Sin"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","article-title":"DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A\/C) mutations","volume":"124","author":"Chen","year":"2019","unstructured":"Chen SN, Lombardi R, Karmouch J, Shi Y, Heeke B, Gulick J, Aronow BJ, Wang M and Taylor MRG. DNA damage response\/TP53 pathway is activated and contributes to the pathogenesis of dilated cardiomyopathy associated with LMNA (Lamin A\/C) mutations. Circ Res 2019; 124: 856-873.","journal-title":"Circ Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1172\/JCI17664","article-title":"A mechanistic role for cardiac myocyte apoptosis in heart failure","volume":"111","author":"Wencker","year":"2003","unstructured":"Wencker D, Chandra M, Nguyen K, Boehm M, Lesch M and Kitsis RN. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003; 111: 1497-1504.","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10741-019-09899-7","article-title":"Advances in the role and mechanism of BAG3 in dilated cardiomyopathy","volume":"26","author":"Liu","year":"2021","unstructured":"Liu L, Sun K, Zhang X, Tang Y and Xu D. Advances in the role and mechanism of BAG3 in dilated cardiomyopathy. Heart Fail Rev 2021; 26: 183-194.","journal-title":"Heart Fail Rev"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Park SM, Yoon JB and Lee TH. Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro. FEBS Lett 2004; 566: 151-156.","DOI":"10.1016\/S0014-5793(04)00477-6"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107886","DOI":"10.1016\/j.celrep.2020.107886","article-title":"Modeling secondary iron overload cardiomyopathy with human induced pluripotent stem cell-derived cardiomyocytes","volume":"32","author":"JW","year":"2020","unstructured":"Rhee JW, Yi H, Thomas D, Schürer S, Spigolon G, Martinez F, Torok-Storb B and Hsieh PC. Modeling secondary iron overload cardiomyopathy with human induced pluripotent stem cell-derived cardiomyocytes. Cell Rep 2020; 32: 107886.","journal-title":"Cell Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis","volume":"127","author":"Fang","year":"2020","unstructured":"Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F and Yu Y. Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ Res 2020; 127: 486-501.","journal-title":"Circ Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.jacc.2018.02.066","article-title":"Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction","volume":"71","author":"Sciarretta","year":"2018","unstructured":"Sciarretta S, Yee D, Nagarajan N, Bianchi F, Saito T, Valenti V, Knöll R and Sadoshima J. Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction. J Am Coll Cardiol 2018; 71: 1999-2010.","journal-title":"J Am Coll Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/15548627.2016.1145326","article-title":"Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis","volume":"12","author":"Saito","year":"2016","unstructured":"Saito T, Asai K, Sato S, Hayashi M, Takahashi T, Takahashi T, Yoshimoto T and Inagaki T. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy 2016; 12: 579-587.","journal-title":"Autophagy"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1093\/hmg\/ddv423","article-title":"PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction","volume":"24","author":"Muhammad","year":"2015","unstructured":"Muhammad E, Levitas A, Singh SR, Braiman A, Ofir R, Etzion S, Argov Z, Shehadeh W and Parvari R. PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction. Hum Mol Genet 2015; 24: 7227-7240.","journal-title":"Hum Mol Genet"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","article-title":"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes","volume":"15","author":"Song","year":"2019","unstructured":"Song H, Feng X, Zhang H, Luo X, Li C, Yu J, Zhang Y and Han H. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes. Autophagy 2019; 15: 1419-1437.","journal-title":"Autophagy"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/joim.13556","article-title":"Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy","volume":"293","author":"Harding","year":"2023","unstructured":"Harding D, Chong MHA, Lahoti N, Ma Z, Siegel D, MacRae CA, Hajjar RJ and Krenz M. Dilated cardiomyopathy and chronic cardiac inflammation: pathogenesis, diagnosis and therapy. J Intern Med 2023; 293: 23-47.","journal-title":"J Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Dilated cardiomyopathy. Nat Rev Dis Primers 2019; 5: 33.","DOI":"10.1038\/s41572-019-0088-x"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10741-020-09940-0","article-title":"Non-ischemic dilated cardiomyopathy and cardiac fibrosis","volume":"26","author":"Cojan-Minzat","year":"2021","unstructured":"Cojan-Minzat BO, Zlibut A and Agoston-Coldea L. Non-ischemic dilated cardiomyopathy and cardiac fibrosis. Heart Fail Rev 2021; 26: 1081-1101.","journal-title":"Heart Fail Rev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1161\/CIRCEP.111.962050","article-title":"Dilated cardiomyopathy","volume":"6","author":"NK","year":"2013","unstructured":"Lakdawala NK, Winterfield JR and Funke BH. Dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2013; 6: 228-237.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.7150\/thno.62302","article-title":"Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice","volume":"11","author":"Wu","year":"2021","unstructured":"Wu W, Ziemann M, Huynh K, Long J, Yellon DM and Hausenloy DJ. Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice. Theranostics 2021; 11: 8993-9008.","journal-title":"Theranostics"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7150\/ijbs.76223","article-title":"Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy","volume":"19","author":"Chang","year":"2023","unstructured":"Chang X, Liu R, Li R, Peng Y, Zhu P and Zhou H. Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy. Int J Biol Sci 2023; 19: 426-448.","journal-title":"Int J Biol Sci"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Tomczyk MM, Cheung KG, Xiang B, Choi B, Balsor JL, Petropolis DB, Tang G, Kozlov G and Al-Omran MG. Mitochondrial sirtuin-3 (SIRT3) prevents doxorubicin-induced dilated cardiomyopathy by modulating protein acetylation and oxidative stress. Circ Heart Fail 2022; 15: e008547.","DOI":"10.1161\/CIRCHEARTFAILURE.121.008547"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1367848","DOI":"10.3389\/fphar.2024.1367848","article-title":"Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy","volume":"15","author":"Wang","year":"2024","unstructured":"Wang H, Cai P, Yu X, Shen B, He X, Zhang L, Liu C, Zhang Z and Chen X. Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy. Front Pharmacol 2024; 15: 1367848.","journal-title":"Front Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Bhide S, Trujillo AS, O’Connor MT, Lee CC, Tharp KM, Ayala JE, Barrett JP, Shackelford DA and Shah S. Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan. Aging Cell 2018; 17: e12747.","DOI":"10.1111\/acel.12747"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"JAJ","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Derks KWJ, Barandiarán Aizpurua A, Merken JJ, Wang P, Weerts J, Gáspárik AS and Heymans S. Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias. Eur Heart J 2018; 39: 864-873.","journal-title":"Eur Heart J"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1367848","DOI":"10.3389\/fphar.2024.1367848","article-title":"Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy","volume":"15","author":"Wang","year":"2024","unstructured":"Wang H, Cai P, Yu X, Li S, Zhu W, Liu Y and Wang D. Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy. Front Pharmacol 2024; 15: 1367848.","journal-title":"Front Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"116185","DOI":"10.1016\/j.biopha.2024.116185","article-title":"N6-methyladenosine RNA methylation in diabetic kidney disease","volume":"171","author":"Huang","year":"2024","unstructured":"Huang J, Yang F, Liu Y and Wang Y. N6-methyladenosine RNA methylation in diabetic kidney disease. Biomed Pharmacother 2024; 171: 116185.","journal-title":"Biomed Pharmacother"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","article-title":"Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis","volume":"27","author":"Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, Qi M, Lu Z and He C. Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res 2017; 27: 1115-1127.","journal-title":"Cell Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/bi00647a024","article-title":"5’-terminal and internal methylated nucleotide sequences in HeLa cell mRNA","volume":"15","author":"CM","year":"1976","unstructured":"Wei CM, Gershowitz A and Moss B. 5’-terminal and internal methylated nucleotide sequences in HeLa cell mRNA. Biochemistry 1976; 15: 397-401.","journal-title":"Biochemistry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1021\/bi00627a023","article-title":"Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid","volume":"16","author":"Wei","year":"1977","unstructured":"Wei CM and Moss B. Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Biochemistry 1977; 16: 1672-1676.","journal-title":"Biochemistry"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2017.10.005","article-title":"Role of N6-methyladenosine modification in cancer","volume":"48","author":"Deng","year":"2018","unstructured":"Deng X, Su R, Feng X, Wei M and Chen J. Role of N6-methyladenosine modification in cancer. Curr Opin Genet Dev 2018; 48: 1-7.","journal-title":"Curr Opin Genet Dev"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ and Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 2019; 20: 608-624.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wu J, Frazier K, Zhang J, Gan Z, Wang T and Fan S. Emerging role of m6A RNA methylation in nutritional physiology and metabolism. Obes Rev 2020; 21: e12942.","DOI":"10.1111\/obr.12942"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01129-8","article-title":"N6-methyladenosine methyltransferases: functions, regulation, and clinical potential","volume":"14","author":"Huang","year":"2021","unstructured":"Huang W, Chen TQ, Fang K, Zeng ZC, Ye H and Chen YQ. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. J Hematol Oncol 2021; 14: 1-19.","journal-title":"J Hematol Oncol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-018-0843-z","article-title":"METTL3 regulates WTAP protein homeostasis","volume":"9","author":"Sorci","year":"2018","unstructured":"Sorci M, Ianniello Z, Cruciani S, Falbo L, Gallo S, Baltaro R, Bachi A and Bonaldi T. METTL3 regulates WTAP protein homeostasis. Cell Death Dis 2018; 9: 796.","journal-title":"Cell Death Dis"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Zhou C, She X, Gu C, Hu Y, Ma M, Qiu Q, Sun T, Xu X, Chen H and Zheng Z. FTO fuels diabetes-induced vascular endothelial dysfunction associated with inflammation by erasing m6A methylation of TNIP1. J Clin Invest. 2023; 133: e160517.","DOI":"10.1172\/JCI160517"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1093\/nar\/gkac195","article-title":"Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes","volume":"50","author":"Kaur","year":"2022","unstructured":"Kaur S, Tam NY, McDonough MA, Schofield CJ and Aik WS. Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes. Nucleic Acids Res 2022; 50: 4148-4160.","journal-title":"Nucleic Acids Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"635808","DOI":"10.3389\/fgene.2021.635808","article-title":"Human ALKBH6 is required for maintenance of genomic stability and promoting cell survival during exposure of alkylating agents in pancreatic cancer","volume":"12","author":"Zhao","year":"2021","unstructured":"Zhao S, Devega R, Francois A, Kidane D, Squire JA and Lopez M. Human ALKBH6 is required for maintenance of genomic stability and promoting cell survival during exposure of alkylating agents in pancreatic cancer. Front Genet 2021; 12: 635808.","journal-title":"Front Genet"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","article-title":"FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair","volume":"139","author":"Mathiyalagan","year":"2019","unstructured":"Mathiyalagan P, Adamiak M, Mayourian J, Liang Y, Agarwal N, Kim R, Zhang S, Nagpal N, Wang K, Sahoo S and Kishore R. FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair. Circulation 2019; 139: 518-532.","journal-title":"Circulation"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/ijms19020555","article-title":"Impact of DNA and RNA methylation on radiobiology and cancer progression","volume":"19","author":"Chi","year":"2018","unstructured":"Chi HC, Tsai CY, Tsai MM and Lin KH. Impact of DNA and RNA methylation on radiobiology and cancer progression. Int J Mol Sci 2018; 19: 555.","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m6A decoration: writers, erasers, readers, and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS and Yang YG. Dynamic transcriptomic m6A decoration: writers, erasers, readers, and functions in RNA metabolism. Cell Res 2018; 28: 616-624.","journal-title":"Cell Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Lu Z, Peng J and Tang J. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 2021; 6: 74.","journal-title":"Signal Transduct Target Ther"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","unstructured":"Shi H, Wei J and He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell 2019; 74: 640-650.","journal-title":"Mol Cell"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tcb.2019.02.008","article-title":"Regulation of gene expression by N6-methyladenosine in cancer","volume":"29","author":"Liu","year":"2019","unstructured":"Liu J, Harada BT and He C. Regulation of gene expression by N6-methyladenosine in cancer. Trends Cell Biol 2019; 29: 487-499.","journal-title":"Trends Cell Biol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X and He C. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 2015; 161: 1388-1399.","journal-title":"Cell"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","unstructured":"Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, Liu C and He C. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. Cell Res 2017; 27: 315-328.","journal-title":"Cell Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","article-title":"A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication","volume":"138","author":"Sheng","year":"2021","unstructured":"Sheng Y, Wei J, Yu F, Xu H, Hu S, Zhu Y, Chen L, Liu Q and Wu C. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. Blood 2021; 138: 2838-2852.","journal-title":"Blood"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y and He C. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife 2017; 6: e31311.","DOI":"10.7554\/eLife.31311"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","article-title":"mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis","volume":"561","author":"Choe","year":"2018","unstructured":"Choe J, Lin S, Zhang W, Liu Q, Wang L, Ramirez-Moya J, Du P and Gregory RI. mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature 2018; 561: 556-560.","journal-title":"Nature"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m6A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R and Gregory RI. The m6A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell 2016; 62: 335-345.","journal-title":"Mol Cell"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.2337\/db19-0906","article-title":"m6A mRNA methylation controls functional maturation in neonatal murine β-cells","volume":"69","author":"Wang","year":"2020","unstructured":"Wang Y, Sun J, Lin Z, Zhou H, Zhang H, Wang S, Wang J, Tang H and Luo Q. m6A mRNA methylation controls functional maturation in neonatal murine β-cells. Diabetes 2020; 69: 1708-1722.","journal-title":"Diabetes"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A and Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ 2021; 28: 2029-2044.","journal-title":"Cell Death Differ"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1172\/JCI17664","article-title":"A mechanistic role for cardiac myocyte apoptosis in heart failure","volume":"111","author":"Wencker","year":"2003","unstructured":"Wencker D, Chandra M, Nguyen K, Khoury DS and Kitsis RN. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003; 111: 1497-1504.","journal-title":"J Clin Invest"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11010-021-04069-6","article-title":"FTO overexpression inhibits apoptosis of hypoxia\/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt","volume":"476","author":"Shen","year":"2021","unstructured":"Shen W, Li H, Su H, Chen K and Yan J. FTO overexpression inhibits apoptosis of hypoxia\/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt. Mol Cell Biochem 2021; 476: 2171-2179.","journal-title":"Mol Cell Biochem"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1002\/ehf2.14059","article-title":"Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy","volume":"9","author":"Fujita","year":"2022","unstructured":"Fujita Y, Yano T, Kanamori H, Yamauchi-Takihara K, Watanabe T and Funakoshi H. Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy. ESC Heart Fail 2022; 9: 3435-3451.","journal-title":"ESC Heart Fail"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12967-017-1189-5","article-title":"Analysis of necroptotic proteins in failing human hearts","volume":"15","author":"Szobi","year":"2017","unstructured":"Szobi A, Gonçalvesová E, Varga ZV, Leszek P and Pacher P. Analysis of necroptotic proteins in failing human hearts. J Transl Med 2017; 15: 86.","journal-title":"J Transl Med"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41423-022-00958-y","article-title":"N6-adenosine methylation (m6A) is involved in the life and death decisions of T cells","volume":"20","author":"Calis","year":"2023","unstructured":"Calis JJA and van Loosdregt J. N6-adenosine methylation (m6A) is involved in the life and death decisions of T cells. Cell Mol Immunol 2023; 20: 316-317.","journal-title":"Cell Mol Immunol"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN and Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012; 149: 1060-1072.","journal-title":"Cell"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via slc7a11-mediated ferroptosis","volume":"127","author":"Fang","year":"2020","unstructured":"Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F and Yu Y. Loss of cardiac ferritin H facilitates cardiomyopathy via slc7a11-mediated ferroptosis. Circ Res 2020; 127: 486-501.","journal-title":"Circ Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s10495-022-01808-y","article-title":"N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis","volume":"28","author":"Shen","year":"2023","unstructured":"Shen H, Xie K, Tian Y and Wang X. N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis. Apoptosis 2023; 28: 514-524.","journal-title":"Apoptosis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"103067","DOI":"10.1016\/j.redox.2024.103067","article-title":"FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21\/Nrf2 activation in a HuR-dependent m6A manner","volume":"70","author":"Yang","year":"2024","unstructured":"Yang Y, Ren J, Zhang J, Shi H, Wang J and Yan Y. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21\/Nrf2 activation in a HuR-dependent m6A manner. Redox Biol 2024; 70: 103067.","journal-title":"Redox Biol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV and Kroemer G. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 2018; 25: 486-541.","journal-title":"Cell Death Differ"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1093\/hmg\/ddv423","article-title":"PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction","volume":"24","author":"Muhammad","year":"2015","unstructured":"Muhammad E, Levitas A, Singh SR, Braiman A, Ofir R, Etzion S and Parvari R. PLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction. Hum Mol Genet 2015; 24: 7227-7240.","journal-title":"Hum Mol Genet"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/15548627.2016.1145326","article-title":"Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis","volume":"12","author":"Saito","year":"2016","unstructured":"Saito T, Asai K, Sato S, Hayashi M, Takahashi T and Inagaki T. Autophagic vacuoles in cardiomyocytes of dilated cardiomyopathy with initially decompensated heart failure predict improved prognosis. Autophagy 2016; 12: 579-587.","journal-title":"Autophagy"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","article-title":"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes","volume":"15","author":"Song","year":"2019","unstructured":"Song H, Feng X, Zhang H, Luo X, Li C, Yu J, Zhang Y and Han H. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes. Autophagy 2019; 15: 1419-1437.","journal-title":"Autophagy"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","unstructured":"Bacmeister L, Schwarzl M, Warnke S, Fleischmann BK and Katus HA. Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol 2019; 114: 19.","journal-title":"Basic Res Cardiol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/ddae029","article-title":"m6A RNA methylation regulates mitochondrial function","volume":"33","author":"Kahl","year":"2024","unstructured":"Kahl M, Xu Z, Arumugam S and Cho JH. m6A RNA methylation regulates mitochondrial function. Hum Mol Genet 2024; 33: 969-980.","journal-title":"Hum Mol Genet"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/HCO.0000000000000616","article-title":"Epigenetics in dilated cardiomyopathy","volume":"34","author":"Yu","year":"2019","unstructured":"Yu J, Zeng C and Wang Y. Epigenetics in dilated cardiomyopathy. Curr Opin Cardiol 2019; 34: 260-269.","journal-title":"Curr Opin Cardiol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"861734","DOI":"10.3389\/fmicb.2022.861734","article-title":"Vitamin D3 suppresses human cytomegalovirus-induced vascular endothelial apoptosis via rectification of paradoxical m6A modification of mitochondrial calcium uniporter mRNA, which is regulated by METTL3 and YTHDF3","volume":"13","author":"Zhu","year":"2022","unstructured":"Zhu W, Zhang H and Wang S. Vitamin D3 suppresses human cytomegalovirus-induced vascular endothelial apoptosis via rectification of paradoxical m6A modification of mitochondrial calcium uniporter mRNA, which is regulated by METTL3 and YTHDF3. Front Microbiol 2022; 13: 861734.","journal-title":"Front Microbiol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","article-title":"Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment","volume":"21","author":"PA","year":"2015","unstructured":"Gorski PA, Ceholski DK and Hajjar RJ. Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment. Cell Metab 2015; 21: 183-194.","journal-title":"Cell Metab"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tibs.2010.07.007","article-title":"Regulation of autophagy by ROS: physiology and pathology","volume":"36","author":"Scherz-Shouval","year":"2011","unstructured":"Scherz-Shouval R and Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 2011; 36: 30-38.","journal-title":"Trends Biochem Sci"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"46583","DOI":"10.1021\/acsami.3c06318","article-title":"Programmed release METTL3-14 inhibitor microneedle protects myocardial function by reducing Drp1 m6A modification-mediated mitochondrial fission","volume":"15","author":"Huang","year":"2023","unstructured":"Huang B, Xie L, Ke M, Wei Y, Zhang Z and Li J. Programmed release METTL3-14 inhibitor microneedle protects myocardial function by reducing Drp1 m6A modification-mediated mitochondrial fission. ACS Appl Mater Interfaces 2023; 15: 46583-46597.","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00018-016-2431-7","article-title":"The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome","volume":"74","author":"Traba","year":"2017","unstructured":"Traba J and Sack MN. The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome. Cell Mol Life Sci 2017; 74: 1777-1791.","journal-title":"Cell Mol Life Sci"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","article-title":"WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy","volume":"27","author":"Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q and Tao Q. WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett 2022; 27: 51.","journal-title":"Cell Mol Biol Lett"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCULATIONAHA.123.066473","article-title":"Nanopore detection of METTL3-dependent m6A-modified mRNA reveals a new mechanism regulating cardiomyocyte mitochondrial metabolism","volume":"149","author":"Rabolli","year":"2024","unstructured":"Rabolli CP, Naarmann-de Vries IS, Makarewich CA, Baskin KK, Dieterich C and Accornero F. Nanopore detection of METTL3-dependent m6A-modified mRNA reveals a new mechanism regulating cardiomyocyte mitochondrial metabolism. Circulation 2024; 149: 1319-1322.","journal-title":"Circulation"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0162038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:59Z","timestamp":1766022959000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0162038.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/aosk8903","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}